Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? (Deficit) Equity

v3.23.2
Condensed Consolidated Statements of Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   10,904,958      
Beginning balance at Dec. 31, 2021 $ 301,731 $ 27 $ 1,475,300 $ 7,538 $ (1,181,134)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss 7,748       7,748
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)   33,744      
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 169   169    
Issuance of Common Stock through settlement of restricted stock units (in shares)   72,690      
Issuance of Common Stock through settlement of restricted stock units 0        
Shares of Common Stock withheld related to net share settlement (in shares)   (24,318)      
Shares of Common Stock withheld related to net share settlement (1,903)   (1,903)    
Stock-based compensation expense 48,704   48,704    
Foreign currency translation adjustment (4,473)     (4,473)  
Ending balance (in shares) at Mar. 31, 2022   10,987,074      
Ending balance at Mar. 31, 2022 351,976 $ 27 1,522,270 3,065 (1,173,386)
Beginning balance (in shares) at Dec. 31, 2021   10,904,958      
Beginning balance at Dec. 31, 2021 301,731 $ 27 1,475,300 7,538 (1,181,134)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (312,569)        
Foreign currency translation adjustment (16,036)        
Ending balance (in shares) at Jun. 30, 2022   11,217,824      
Ending balance at Jun. 30, 2022 63,784 $ 28 1,565,956 (8,498) (1,493,703)
Beginning balance (in shares) at Mar. 31, 2022   10,987,074      
Beginning balance at Mar. 31, 2022 351,976 $ 27 1,522,270 3,065 (1,173,386)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (320,316)       (320,316)
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)   9,148      
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 88   88    
Issuance of Common Stock through settlement of restricted stock units (in shares)   224,483      
Issuance of Common Stock through settlement of restricted stock units 1 $ 1      
Shares of Common Stock withheld related to net share settlement (in shares)   (5,778)      
Shares of Common Stock withheld related to net share settlement (108)   (108)    
Issuance of Commitment Fee Shares (in shares)   2,897      
Issuance of Commitment Fee Shares 56   56    
Stock-based compensation expense 43,650   43,650    
Issuance of Redeemable Convertible Senior Preferred Stock, net of derivatives and issuance costs, and accrual of paid-in kind dividends (in shares)        
Issuance of Redeemable Convertible Senior Preferred Stock, net of derivatives and issuance costs, and accrual of paid-in kind dividends 0      
Foreign currency translation adjustment (11,563)     (11,563)  
Ending balance (in shares) at Jun. 30, 2022   11,217,824      
Ending balance at Jun. 30, 2022 63,784 $ 28 1,565,956 (8,498) (1,493,703)
Beginning balance (in shares) at Dec. 31, 2022   11,889,227      
Beginning balance at Dec. 31, 2022 25,110 $ 30 1,572,576 (7,621) (1,539,875)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (44,318)       (44,318)
Issuance of Common Stock through Bird Canada Inc. acquisition transaction (in shares)   728,175      
Issuance of Common Stock through Bird Canada Inc. acquisition transaction 3,696 $ 2 3,694    
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)   50,097      
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 205   205    
Issuance of Common Stock through settlement of restricted stock units (in shares)   97,682      
Issuance of Common Stock through settlement of restricted stock units 0        
Shares of Common Stock withheld related to net share settlement (in shares)   (535)      
Shares of Common Stock withheld related to net share settlement (4)   (4)    
Stock-based compensation expense 7,280   7,280    
Foreign currency translation adjustment 461     461  
Ending balance (in shares) at Mar. 31, 2023   12,764,646      
Ending balance at Mar. 31, 2023 (7,570) $ 32 1,583,751 (7,160) (1,584,193)
Beginning balance (in shares) at Dec. 31, 2022   11,889,227      
Beginning balance at Dec. 31, 2022 25,110 $ 30 1,572,576 (7,621) (1,539,875)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (53,628)        
Foreign currency translation adjustment 450        
Ending balance (in shares) at Jun. 30, 2023   12,793,527      
Ending balance at Jun. 30, 2023 (10,925) $ 32 1,589,717 (7,171) (1,593,503)
Beginning balance (in shares) at Mar. 31, 2023   12,764,646      
Beginning balance at Mar. 31, 2023 (7,570) $ 32 1,583,751 (7,160) (1,584,193)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (9,310)       (9,310)
Issuance of Common Stock through Bird Canada Inc. acquisition transaction (in shares)        
Issuance of Common Stock through Bird Canada Inc. acquisition transaction 0    
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)   28,793      
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 45   45    
Issuance of Common Stock through settlement of restricted stock units (in shares)   88      
Issuance of Common Stock through settlement of restricted stock units 0        
Shares of Common Stock withheld related to net share settlement (in shares)        
Shares of Common Stock withheld related to net share settlement 0      
Stock-based compensation expense 5,921   5,921    
Foreign currency translation adjustment (11)     (11)  
Ending balance (in shares) at Jun. 30, 2023   12,793,527      
Ending balance at Jun. 30, 2023 $ (10,925) $ 32 $ 1,589,717 $ (7,171) $ (1,593,503)